Literature DB >> 10337012

Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.

M Takahashi1, N Ishimaru, K Yanagi, K Saegusa, N Haneji, H Shiota, Y Hayashi.   

Abstract

Injection of antigen into the anterior chamber of the eye induces suppression of antigen-specific DTH, called anterior chamber-associated immune deviation (ACAID). It has been shown that the spleen is required for the induction of ACAID and detecting the ACAID-inducing signal from the eye. To examine the in vivo role of spleen cells, fractions of spleen cells were adoptively transferred into splenectomized mice. The present study showed that DTH was not suppressed in splenectomized mice, but was inhibited in splenectomized mice transferred with a primed CD4+ T cell-containing fraction of spleen cells. This indicates that the splenic CD4+ T cells comprise the regulatory T cells for the DTH response. When we examined the cytokine profile of the infiltrating T cells in the eye of primed mice by reverse transcriptase-polymerase chain reaction (RT-PCR), we found that they expressed IL-4, IL-10 mRNA (Th2 type), but not IL-2 and interferon-gamma (IFN-gamma) mRNA (Th1 type). By contrast, T cells which can elicit normal DTH response expressed IL-2 and IFN-gamma mRNA. These results suggest that splenic CD4+ T cells comprising the regulatory phenotype are required for the induction of ACAID, and that a DTH response to the antigen may be prevented by Th2-dominant CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337012      PMCID: PMC1905278          DOI: 10.1046/j.1365-2249.1999.00854.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

2.  CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.

Authors:  T S Griffith; X Yu; J M Herndon; D R Green; T A Ferguson
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

3.  Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.

Authors:  M M Kosiewicz; J W Streilein
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Role of splenic B cells in the immune privilege of the anterior chamber of the eye.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

5.  The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.

Authors:  T S Griffith; J M Herndon; J Lima; M Kahn; T A Ferguson
Journal:  Int Immunol       Date:  1995-10       Impact factor: 4.823

6.  TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.

Authors:  H Maeda; A Shiraishi
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

7.  Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor.

Authors:  A W Taylor; J W Streilein; S W Cousins
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

8.  Neuropeptides modulate immune deviation induced via the anterior chamber of the eye.

Authors:  T A Ferguson; S Fletcher; J Herndon; T S Griffith
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity.

Authors:  L Li; J F Elliott; T R Mosmann
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

10.  Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon.

Authors:  A W Taylor; J W Streilein; S W Cousins
Journal:  Neuroimmunomodulation       Date:  1994 May-Jun       Impact factor: 2.492

View more
  6 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.

Authors:  Michael G Strainic; Jinbo Liu; Fengqi An; Erin Bailey; Andrew Esposito; Jörg Hamann; Peter S Heeger; M Edward Medof
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

3.  Lipopolysaccharide/interferon-gamma and not transforming growth factor beta inhibits retinal microglial migration from retinal explant.

Authors:  D A Carter; A D Dick
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  Involvement of Foxp3-expressing CD4+ CD25+ regulatory T cells in the development of tolerance induced by transforming growth factor-beta2-treated antigen-presenting cells.

Authors:  Haining Zhang; Peizeng Yang; Hongyan Zhou; Qianli Meng; Xiangkun Huang
Journal:  Immunology       Date:  2008-02-11       Impact factor: 7.397

5.  CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.

Authors:  Xuefei Zhu; Peizeng Yang; Hongyan Zhou; Bing Li; Xiangkun Huang; Qianli Meng; Li Wang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-31       Impact factor: 3.117

6.  A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.

Authors:  Fang Lei; Junfeng Zhang; Jinsong Zhang; Hao He; Ying Du; Peizeng Yang
Journal:  Mol Vis       Date:  2008-02-11       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.